iShares Biotechnology ETF (NASDAQ:IBB) Stock Position Increased by Global Retirement Partners LLC

Global Retirement Partners LLC boosted its position in iShares Biotechnology ETF (NASDAQ:IBB) by 118.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 35,172 shares of the financial services provider’s stock after purchasing an additional 19,049 shares during the quarter. Global Retirement Partners LLC’s holdings in iShares Biotechnology ETF were worth $4,650,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Huntington National Bank lifted its position in iShares Biotechnology ETF by 17.9% in the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock valued at $153,000 after purchasing an additional 160 shares during the last quarter. National Bank of Canada FI raised its position in shares of iShares Biotechnology ETF by 5.9% during the 3rd quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock worth $600,000 after buying an additional 229 shares in the last quarter. Avior Wealth Management LLC raised its position in shares of iShares Biotechnology ETF by 438.2% during the 3rd quarter. Avior Wealth Management LLC now owns 3,229 shares of the financial services provider’s stock worth $470,000 after buying an additional 2,629 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its position in shares of iShares Biotechnology ETF by 32.9% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after buying an additional 164,000 shares in the last quarter. Finally, Main Management ETF Advisors LLC raised its position in shares of iShares Biotechnology ETF by 2.5% during the 3rd quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock worth $86,395,000 after buying an additional 14,535 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

IBB stock opened at $138.74 on Thursday. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57. The firm’s 50-day moving average is $135.53 and its two-hundred day moving average is $140.79.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.